| __timestamp | Arrowhead Pharmaceuticals, Inc. | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 23138050 | 1488000000 |
| Thursday, January 1, 2015 | 57410147 | 1525000000 |
| Friday, January 1, 2016 | 41454452 | 2111000000 |
| Sunday, January 1, 2017 | 31690298 | 1848000000 |
| Monday, January 1, 2018 | 52968505 | 1213000000 |
| Tuesday, January 1, 2019 | 81048686 | 1010000000 |
| Wednesday, January 1, 2020 | 128874979 | 997000000 |
| Friday, January 1, 2021 | 206342000 | 967000000 |
| Saturday, January 1, 2022 | 297307000 | 838000000 |
| Sunday, January 1, 2023 | 353188000 | 953000000 |
| Monday, January 1, 2024 | 505870000 | 998000000 |
In pursuit of knowledge
In the competitive landscape of pharmaceuticals, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Teva Pharmaceutical Industries Limited and Arrowhead Pharmaceuticals, Inc. have demonstrated contrasting strategies in their R&D investments.
From 2014 to 2023, Teva's R&D expenses have shown a downward trend, decreasing by approximately 36% from their peak in 2016. This shift reflects Teva's strategic realignment amidst industry challenges. In contrast, Arrowhead has significantly ramped up its R&D spending, with a remarkable increase of over 2,000% during the same period, highlighting its aggressive pursuit of cutting-edge therapies.
As of 2023, Arrowhead's R&D expenditure reached its highest, while Teva's data for 2024 remains unavailable. This divergence underscores the dynamic nature of pharmaceutical innovation and the varied paths companies take to achieve growth.
Who Prioritizes Innovation? R&D Spending Compared for AstraZeneca PLC and Arrowhead Pharmaceuticals, Inc.
Comparing Innovation Spending: Novartis AG and Teva Pharmaceutical Industries Limited
GSK plc or Arrowhead Pharmaceuticals, Inc.: Who Invests More in Innovation?
Research and Development Investment: Takeda Pharmaceutical Company Limited vs Arrowhead Pharmaceuticals, Inc.
Research and Development Investment: Teva Pharmaceutical Industries Limited vs Summit Therapeutics Inc.
Analyzing R&D Budgets: Teva Pharmaceutical Industries Limited vs Rhythm Pharmaceuticals, Inc.
R&D Insights: How Teva Pharmaceutical Industries Limited and HUTCHMED (China) Limited Allocate Funds
Comparing Innovation Spending: Teva Pharmaceutical Industries Limited and Ligand Pharmaceuticals Incorporated
Comparing Innovation Spending: Ionis Pharmaceuticals, Inc. and Arrowhead Pharmaceuticals, Inc.
Research and Development Investment: Arrowhead Pharmaceuticals, Inc. vs ImmunityBio, Inc.
R&D Spending Showdown: Arrowhead Pharmaceuticals, Inc. vs Wave Life Sciences Ltd.
Research and Development Investment: Arrowhead Pharmaceuticals, Inc. vs Mesoblast Limited